267 studies found for:    "Expanded Access" [STUDY-TYPES]
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Approved for marketing VX-770 Expanded Access Program
Condition: Cystic Fibrosis
Intervention: Drug: VX-770
2 Approved for marketing The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol
Condition: Hemoglobinuria, Paroxysmal
Intervention: Drug: eculizumab
3 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
4 Available An Extended Access Program for Perampanel
Condition: Partial Onset Seizures
Intervention: Drug: Perampanel
5 Available 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS);   Congenital Myasthenia (CM)
Intervention: Drug: 3,4-diaminopyridine
6 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
7 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
8 Available Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Condition: Chronic Myeloid Leukemia
Intervention: Drug: bosutinib
9 Available Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4 DAP
10 Approved for marketing Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant
Conditions: Breast Augmentation;   Breast Reconstruction;   Breast Revision
Intervention: Device: Mentor Siltex® Contour Profile Gel Mammary Prosthesis
11 Approved for marketing ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.
Condition: Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
12 Approved for marketing A Belatacept Compassionate Use Study for Patients With a Kidney Transplant
Condition: Renal Transplantation
Intervention: Drug: Belatacept
13 Approved for marketing Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: MDV3100
14 No longer available Post Marketing Surveillance Study of Cuprimine
Condition: Scleroderma
Intervention: Drug: Cuprimine (penicillamine)
15 No longer available Use of the Pressure Right Device After Laparoscopic Surgery
Conditions: Nausea;   Vomiting
Intervention: Device: Acupressure
16 No longer available YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access
Condition: Soft Tissue Sarcoma
Intervention: Drug: Trabectedin
17 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
18 Approved for marketing Emergency/Compassionate Use - Muscular VSD Occluder
Conditions: Muscular;   Ventricular;   Septal;   Defects;   VSD
Intervention: Device: AMPLATZER Muscular VSD Occluder
19 Approved for marketing A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
Condition: Gastrointestinal Neoplasm
Intervention: Drug: Sutent
20 Unknown  Clinical Research on the Efficacy of Acupuncture Treatment in Chronic Low Back Pain
Conditions: Chronic Low Back Pain;   Acupuncture
Intervention: Device: Acupuncture, Pak-sham needle

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years